The mean bilateral proximal extension of the clot is associated with pulmonary embolism severity parameters and management-associated outcomes.


Journal

Acta radiologica (Stockholm, Sweden : 1987)
ISSN: 1600-0455
Titre abrégé: Acta Radiol
Pays: England
ID NLM: 8706123

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 27 10 2020
medline: 21 10 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

The value of the proximal extension of the clot in risk stratification of pulmonary embolism (PE) has not been established. The mean bilateral proximal extension of the clot (MBPEC) is a computed tomography (CT) radiological score, where initial evaluation showed promising results considering its ability in predicting the severity of PE. To explore the possible associations between MBPEC and PE-severity parameters, short- and long-term outcomes of PE, and inter-observer agreement. Patients diagnosed with PE at Østfold Hospital, Norway during 2003-2011 were identified. MBPEC was calculated by calculating the mean of a score in the range of 1-4 assigned for the most proximal extension of the clot in each lung: sub-segmental; segmental; lobar; and main pulmonary arteries. Medical records were reviewed to capture clinical, biochemical, and management-associated data (thrombolysis, admission to ICU). The mean age of 245 included patients was 55 ± 16 years; 42% were women. Patients with higher MBPEC scores had a significantly higher pulse rate and lower oxygen saturation. MBPEC score <4 predicted a negative troponin value with a negative predictive value of 90% (95% confidence interval [CI] 81-95). Patients with MBPEC 4 were 5.3 times more likely to have elevated troponin (odds ratio [OR] 5.3, 95% CI 2.0-14.3). MBPEC score of 4 was independently associated with admission to ICU (OR 3.8, 95% CI 1.8-7.9). The inter-observer agreement was excellent; weighted kappa 0.82. MBPEC is associated with PE-severity parameters and can predict short-term adverse outcomes.

Sections du résumé

BACKGROUND BACKGROUND
The value of the proximal extension of the clot in risk stratification of pulmonary embolism (PE) has not been established. The mean bilateral proximal extension of the clot (MBPEC) is a computed tomography (CT) radiological score, where initial evaluation showed promising results considering its ability in predicting the severity of PE.
PURPOSE OBJECTIVE
To explore the possible associations between MBPEC and PE-severity parameters, short- and long-term outcomes of PE, and inter-observer agreement.
MATERIAL AND METHODS METHODS
Patients diagnosed with PE at Østfold Hospital, Norway during 2003-2011 were identified. MBPEC was calculated by calculating the mean of a score in the range of 1-4 assigned for the most proximal extension of the clot in each lung: sub-segmental; segmental; lobar; and main pulmonary arteries. Medical records were reviewed to capture clinical, biochemical, and management-associated data (thrombolysis, admission to ICU).
RESULTS RESULTS
The mean age of 245 included patients was 55 ± 16 years; 42% were women. Patients with higher MBPEC scores had a significantly higher pulse rate and lower oxygen saturation. MBPEC score <4 predicted a negative troponin value with a negative predictive value of 90% (95% confidence interval [CI] 81-95). Patients with MBPEC 4 were 5.3 times more likely to have elevated troponin (odds ratio [OR] 5.3, 95% CI 2.0-14.3). MBPEC score of 4 was independently associated with admission to ICU (OR 3.8, 95% CI 1.8-7.9). The inter-observer agreement was excellent; weighted kappa 0.82.
CONCLUSION CONCLUSIONS
MBPEC is associated with PE-severity parameters and can predict short-term adverse outcomes.

Identifiants

pubmed: 33100028
doi: 10.1177/0284185120966724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1309-1316

Auteurs

Mazdak Tavoly (M)

Medical Division, Østfold Hospital, Sarpsborg, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Jostein Gleditsch (J)

Department of Radiology, Østfold Hospital, Sarpsborg, Norway.

Josef P Ghanima (JP)

Medical Division, Østfold Hospital, Sarpsborg, Norway.

Fredrik Bremtun (F)

Medical Division, Østfold Hospital, Sarpsborg, Norway.

Martin Schintzkewitz (M)

Department of Radiology, Østfold Hospital, Sarpsborg, Norway.

Karl Julius Thrane (KJ)

Department of Radiology, Østfold Hospital, Sarpsborg, Norway.

Oyvind Jervan (O)

Medical Division, Østfold Hospital, Sarpsborg, Norway.

Waleed Ghanima (W)

Medical Division, Østfold Hospital, Sarpsborg, Norway.
Department of Haematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH